Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7508 Pharmaceutical Companies

Closed 09-03 16:00:00 AEST

670.58

+6.36

+0.96%

High671.75	Low664.07	Vol62.23M
Open664.65	D1 Closing664.23	Amplitude1.16%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O146.51M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":670.5847,"timestamp":1788415199698,"preClose":664.22894,"halted":0,"volume":62234571,"delay":0,"changeRate":0.009569,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":6.355774,"latestTime":"09-03 16:00:00 AEST","open":664.65094,"high":671.7475,"low":664.0652,"amount":146505001,"amplitude":0.011566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788393600000,1788415200000]],"turnoverRate":0.002487,"increases":15,"decrements":10,"flats":17,"marketCap":94672061691.25,"floatMarketCap":91327774327.625},"requestUrl":"/m/hq/s/BK7508/tweets","defaultTab":"tweets","newsList":[{"id":"2664601823","title":"ASX Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664601823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664601823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:04","pubTimestamp":1788401097,"startTime":"0","endTime":"0","summary":"The Australian stock market is poised for a positive start today, with the ASX expected to open higher following a rebound on Wall Street. Amidst this backdrop of fluctuating indices and evolving economic trends, investors are increasingly looking at opportunities in less conventional areas. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present valuable opportunities when they possess strong financial foundations and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BVS.AU","MSB.AU","KSC.AU","BK7503","BK7016","BK7067","BK7501","BK7058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842977","title":"Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842977","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842977?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:46","pubTimestamp":1788392770,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing ModuleSept 3 -Imricor Medical Systems, IncIMR.AX:IMRICOR MEDICAL SYSTEMS, INC-FDA ACCEPTS IMRICOR PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA ACCEPTS AND CLOSES IMRICOR'S PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA TO CONDUCT PRE-APPROVAL INSPECTION OF IMRICOR'S MANUFACTURING SITESFurther company coverage:IMR.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7508","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664426518","title":"Black Box Warning on CSL's Injectafer Unlikely to Change Much","url":"https://stock-news.laohu8.com/highlight/detail?id=2664426518","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664426518?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:34","pubTimestamp":1788392040,"startTime":"0","endTime":"0","summary":"2329 GMT [Dow Jones]--The addition of a black box warning to the label of CSL's Injectafer is unlikely to have a big impact, according to Citi. The Food and Drug Administration approved revised labeling for the iron replacement medicine to warn of the risk of low levels of phosphate in the blood. \"We do not think it will change much,\" says Citi. \"Generics to Injectafer have become available over the last few weeks and, per FDA, are expected to update their labels also.\" Citi has a neutral rating and A$160/share target on CSL. The stock ended Wednesday at A$173.85.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7511","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844156","title":"Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844156?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664784413","title":"Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784413?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7508","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999896","title":"Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999896","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999896?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:38","pubTimestamp":1788327489,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  reached the pre-specified enrollment threshold for its first planned dose optimization committee review in a phase 2a study of its PTX-100 drug candidate in relapsed or refractory cutaneous T-cell lymphoma, according to a Wednesday filing with the Australian bourse.The company said 10 evaluable patients, or those who have completed four cycles of treatment, are now enrolled in each of the study's two dosing arms for 20 evaluable patients in total.The first dose optimization committee review remains on track for December, and enrollment in the study continues globally toward a full target of 40 evaluable patients.Cutaneous T-cell lymphoma is a type of immune system cancer where abnormal white blood cells migrate to and attack the skin.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PTX.AU","BK4007","BK7067","BK4539","LENZ","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664918898","title":"CSL Bulls Don't See Large Impact from U.S. Pricing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664918898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664918898?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:29","pubTimestamp":1788316140,"startTime":"0","endTime":"0","summary":"0229 GMT - CSL's bulls at UBS don't think the Australia-based pharmaceutical company will experience much of a direct financial impact from its U.S. pricing agreements. CSL has agreed to give Medicaid access to medicines at prices comparable to those in other developed economies, but the investment bank's analysts point out that the state-based program accounts for a relatively small part of its U.S. sales. On top of that, they don't see obligations around the pricing of future drug launches as onerous, given that CSL will be in control of settings and able to manage the impact in its best interests. UBS has a last-published buy rating on the stock and a target price of 181.00 Australian dollars. Shares are up 0.5% at A$173.12.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664862357","title":"Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2664862357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664862357?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:58","pubTimestamp":1788307093,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T18J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864668","title":"Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864668?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:43","pubTimestamp":1788302639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664675118","title":"Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664675118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664675118?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:26","pubTimestamp":1788297996,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADO.AU","BK7036","BK7048","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664320861","title":"ASX Growth Companies With High Insider Ownership You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664320861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664320861?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:08","pubTimestamp":1788289704,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7093","SKS.AU","TLX.AU","VAP.AU","LTR.AU","QFN.AU","BK7067","TTT.AU","BK7508","WZR.AU","AR1.AU","BK7096","ZYAU.AU","AV1.AU","BBOZ.AU","BK7137","DACE.AU","VAS.AU","OZR.AU","SPL.AU","BK4139","OZF.AU","E200.AU","EIGA.AU","AWJ.AU","BK7104","STW.AU","GIVE.AU","FRS.AU","BEAR.AU","XAO.AU","IIGF.AU","BK7110","IMLC.AU","BK7036","QRE.AU","SLF.AU","BK7016","BK7504","PDI.AU","EIQ.AU","BK7501","TLX","XJO.AU","GEAR.AU","XKO.AU","IOZ.AU","GYG.AU","IISV.AU","BK7023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861352","title":"3 ASX Stocks Estimated To Be Undervalued In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861352?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:05","pubTimestamp":1788289503,"startTime":"0","endTime":"0","summary":"As geopolitical tensions in the Middle East contribute to volatility in global markets, the Australian Stock Exchange (ASX) is feeling the impact with a cautious start, influenced by fluctuating oil prices and broader economic concerns. In such uncertain times, identifying undervalued stocks can offer potential opportunities for investors seeking resilience amidst market fluctuations.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7039","BK7017","LOV.AU","BK7062","BK4526","BK7508","BK7016","BK4543","GNP.AU","MP1.AU","SLC.AU","TEA.AU","BK4585","NXL.AU","BK7126","BK7094","BK7503","BK7120","BMT.AU","PNV.AU","CAT.AU","ASX.AU","BK7043","ASX","SPHQ","STH.AU","BK7061","BK4141","BK7128","BK7015","BK4588","BK7084","NDO.AU","BK7055","PNI.AU","SDV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664548468","title":"PAR Technology Launches Platform to Connect Restaurant Guest Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2664548468","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664548468?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:17","pubTimestamp":1788268623,"startTime":"0","endTime":"0","summary":"PAR Technology  said Tuesday it has launched a new customer data platform to recognize restaurant guests from their first transaction and unify activity across ordering, payment and other channels.The Guest360 platform works alongside PAR Punchh to create unified guest profiles from in-store, digital and loyalty activity, PAR Technology said.The platform can use the profiles to create dynamic audiences that update automatically based on real spend, visit frequency, menu preference for personalized offers and loyalty milestones, it said.PAR Technology shares were 2% lower in Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4157","PAR","QSR","BK4209","BK7067","BK7508","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU0345769631.USD","LU0158827781.USD","LU2063271972.USD","LU2552382058.USD","LU2211815571.USD","SG9999015341.SGD","LU2357627491.SGD","LU2430703095.HKD","IE00BWXC8680.SGD","LU2360106947.USD","SG9999014567.USD","LU0158827948.USD","LU0708995401.HKD","LU0823416689.USD","LU1868837300.USD","BK4559","LU1989772923.USD","LU2111349929.HKD","688235","IE00BN8TJ469.HKD","LU1236620834.HKD","LU1003077747.HKD","LU1244550221.USD","LU2433249047.HKD","MHIP","IE00BJLML261.HKD","LU1670627923.USD","LU2491050071.SGD","LU0316494557.USD","GLAM","LU1116320737.USD","LU1571399168.USD","LU0029864427.USD","LU1551013425.SGD","GSK.UK","LU0320765646.SGD","LU0211328371.USD","SG9999015978.USD","LU0980610538.SGD","BK7067","LU0477156953.USD","LU0994945656.USD","LU2168564495.EUR","LU0069063385.USD","IE00BJJMRY28.SGD","LU0345770993.USD","BIB","LU1061106388.HKD","LU1883839398.USD","LU0321505868.SGD","LU1585245621.USD","IE00BVYPNW00.USD","LU0795875086.SGD","LU1267930490.SGD","LU1934455194.USD","LU0170899867.USD","LU0006306889.USD","LU1988902786.USD","LU2347655073.USD","LU0234572021.USD","SGXZ51526630.SGD","LU0943347566.SGD","LU2089284900.SGD","LU1941712348.USD","LU2023250330.USD","LU1732800096.USD","LU2028103732.USD","IE00BFSS8Q28.SGD","LU1712237335.SGD","LU0072461881.USD","LU2362540622.SGD","LU1244550494.USD","LU1894683348.USD","LU2089283258.USD","LU2471134523.USD","IE000WAW04H5.SGD","LU1868836591.USD","LU2023251221.USD","IE000M9KFDE8.USD","TRUH","LU1868837136.USD","LU1280957306.USD","LU1894683264.USD","LU1829250122.USD","HRTS","LU0211327993.USD","SG9999002232.USD","LU0964807845.USD","LU2456880835.USD","LU2552382132.HKD","IE00BN29S564.USD","LU2361044949.HKD","LU2430703178.SGD","LU0823434740.USD","PBE","BK4550","LU1868836914.USD","LU0511384066.AUD","LU1074936037.SGD","IBBQ","BK4583","LU0122379950.USD","LU2271345857.HKD","GSKH","LU2125154778.USD","IYH","LU1057294990.SGD","LU2237443978.SGD","LU1261432733.SGD","SG9999015358.SGD","LU0426412945.USD","LU2505996681.GBP","LU0162691827.USD","LU0985481810.HKD","BK4581","LU0432979614.USD","LU2087621335.USD","LU0234570918.USD","LLYX","LU0154236417.USD","SG9999001176.USD","LLY","LU0889566641.SGD","LLYZ","LU2471134879.HKD","LU0323591593.USD","LU1629891620.HKD","LU2168564222.USD","SG9999014880.SGD","IE00BKVL7J92.USD","LU0868494708.USD","LU2237443465.HKD","LU2491049909.HKD","LU2361045086.USD","LU1064131342.USD","LU0225284248.USD","LU1496350171.SGD","LU2129689431.USD","IE0004445015.USD","LU0203345920.USD","LU0289739343.SGD","LU1232071149.USD","LU2237443549.SGD","LU2112291526.USD","LU2133065610.SGD","LU0133085943.USD","LU1929549753.HKD","LU1032466523.USD","LU2430703251.USD","LU2237438978.USD","LU2746668974.SGD","OZEM","VHT","LU0354030511.USD","LU0208291251.USD","LU2125909247.SGD","PAWZ","LU2347655156.SGD","SG9999014898.SGD","LU2236285917.USD","LU0070217475.USD","RXL","LU1430594728.SGD","AZN","LU1196500208.SGD","IE0005OL40V9.USD","BK4007","LU0070302665.USD","IE00BSNM7G36.USD","LU1221951046.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","LU0689472784.USD","NVOX","LU1267930573.SGD","LU0130517989.USD","LU2746668461.USD","LU2168564065.EUR","LU2471134952.CNY","LU1814569148.SGD","THNR","IE00B775H168.HKD","LU1934455863.HKD","SG9999018865.SGD","LU2237443895.HKD","LU0471298694.HKD","LU2750360641.GBP","JNJ","LU0174119429.USD","LU2213496289.HKD","LU2602419157.SGD","LU0266013472.USD","LU1983299246.USD","LU0320765489.SGD","LU2552382215.SGD","LU0289739699.SGD","NVOH","IE0002270589.USD","PFE","LU1868836757.USD","LU1116320901.HKD","LU1718418525.SGD","LU2023250843.SGD","LU1720051017.SGD","LU1914381329.SGD","LU0471298777.SGD","IHE","GB00BDT5M118.USD","LU1804176565.USD","LU2264538146.SGD","IE00BBT3K403.USD","LU2596442595.SGD","LU0096364046.USD","NVOC","BK0239","LU0949170772.SGD","BMED","BK4599","LU2108987350.USD","SG9999001440.SGD","LU1043141396.HKD","IBB","FTXH","LU0306807586.USD","IE00B2B36J28.USD","SG9999001176.SGD","LU1066051811.HKD","SG9999017495.SGD","LU2361044865.SGD","IE00B42XCP33.USD","WDNA","LU0210536198.USD","GDOC","BK4504","LU2129689514.USD","LU0965509010.AUD","LU1066051225.USD","LU1267930813.SGD","LU1228905037.USD","LU2362541273.HKD","BK7511","IE00BK4W5L77.USD","LU0472753341.HKD","LU1127390331.HKD","BBIO","PJP","LU0545039389.USD","LU2242652126.USD","LU1674673691.USD","LU1059921491.USD","LU1069344957.HKD","LU2750360997.AUD","BK4585","LU0225283273.USD","LU0238689110.USD","LU1023059063.AUD","BBH","LU0823434583.USD","LU0861579265.USD","LU1974910355.USD","SG9999015986.USD","LU1035775433.USD","LU1236620750.USD","IE000BZT7R73.USD","LU2168563687.JPY","LU0061475181.USD","LU0310800379.SGD","SG9999014906.USD","LU2462157665.USD","LU0395794307.EUR","LU0672654240.SGD","LU2491050154.USD","REGN","LU2360032135.SGD","SG9999014914.USD","SG9999003800.SGD","LU0128525929.USD","LU2487616109.SGD","LU2471134796.USD","ILDR","LU1670711123.USD","LU0889565916.HKD","LU0321505439.SGD","LU1069347547.HKD","MRK","IE00BLSP4239.USD","NVO","LU2403377893.USD","LU2461242641.AUD","LU1778281490.HKD","LU0058720904.USD","LU2237443382.USD","LU2125154935.USD","ELIL","IE00BKDWB100.SGD","LU1720051108.HKD","LU0109394709.USD","BK7501","LU0203202063.USD","LU0738911758.USD","ABBV","BK4566","LU1674673428.USD","LU1093756168.USD","LU2324357040.USD","04332","LU1496350502.SGD","SG9999013999.USD","LU0079474960.USD","LU1145028129.USD","LU1941712264.USD","LU1093756325.SGD","IE00B1XK9C88.USD","BK4534","SG9999011175.SGD","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","IE00BKPKM429.USD","BK4505","IE00BFSS7M15.SGD","LU0210528500.USD","IE0004445239.USD","ONC","LU0114720955.EUR","LU0553294199.USD","LU0882574055.USD","LU0320765992.SGD","LU2505996509.AUD","IE00B4R5TH58.HKD","LU1691799644.USD","IE00BFXG1179.USD","LU0965509283.SGD","CANC","LU1037948541.HKD","LU1934455277.USD","LU0097036916.USD","LU1066051498.USD","SG9999014542.SGD","LU1935042991.SGD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU1839511570.USD","LU0320765059.SGD","IE00B3T34201.USD","LU0708994859.HKD","MEDI","PPH","SGXZ31699556.SGD","LU0726765562.USD","LU0109391861.USD","LU0820562030.AUD","BK4516","SG9999014575.USD","LU2087625088.SGD","MEDX","SG9999015945.SGD","LU0985320562.USD","LU0124676726.USD","LU2417539215.USD","LU1623119135.USD","LU0353189763.USD","LU0689626769.HKD","LU2756315318.SGD","LU0267386448.USD","IE000SO60NU8.SGD","IE00BJJMRX11.SGD","LU2106854487.HKD","LU2125909593.SGD","LU1035773651.USD","LU0198837287.USD","NVS","AZNH","LU0211331839.USD","LU0820561818.USD","LU0094547139.USD","LU0057025933.USD","LU1291159041.SGD","LU1366192091.USD","IE00B3PB1722.GBP","IE00B4JS1V06.HKD","LU2168564149.EUR","LU0265550946.USD","BK7508","LU1917777945.USD","SGXZ80539844.SGD","LU0203347892.USD","LU2592432038.USD","LU1066053197.SGD","LU0456855351.SGD","LU0417517546.SGD","LU1989771016.USD","LU1032955483.USD","IE0002141913.USD","GSK","LU1923622614.USD","LU0545562505.USD","BK4578","IXJ","LU1506573853.SGD","SGXZ99366536.SGD","LU0130102774.USD","LU1228905540.USD","LU0354030438.USD","LU0942090050.USD","IE0009355771.USD","JDOC","LU0098860793.USD","LU0661504455.SGD","LU1548497426.USD","LU0106261372.USD","LU0820561909.HKD","IE00B19Z3B42.SGD","TBXU","LU2089984988.USD","LU0640476718.USD","LU0868494617.USD","LU0795875169.SGD","LU1323610961.USD","CSL.AU","IE00B7SZLL34.SGD","LU1162221912.USD","LU2357305700.SGD","LU1699723380.USD","LU0256863811.USD","SGXZ81514606.USD","SG9999015952.SGD","IE00B19Z3581.USD","BK4533","IE00BVYPNV92.GBP","LU0306806265.USD","LU2468319806.SGD","LU0466842654.USD","BK4588","IE0034235303.USD","LU0053666078.USD","AMGN","GILD","LU1267930730.SGD","LU2462591350.SGD","LU0310799852.SGD","LU0882574139.USD","LU0965508806.USD","LU1221951129.SGD","LU1989772840.SGD","LU0203201768.USD","IE00BJT1NW94.SGD","IE0001KFT4U8.USD","LU2362541513.USD","LU1670628061.USD","LU0912757837.SGD","LU0792757196.USD","IE0000B7K699.USD","LU0256863902.USD","LU2896262040.SGD","LU0426417589.USD","XLV","BK4568","LU1121112475.USD","BMY","BK4532","LU1551013342.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SG9999018857.SGD","LU0786609619.USD","LU0225771236.USD","LU2756315664.SGD","LU1670711040.USD","BK4592","06160","IE00B7KXQ091.USD","LU0859254822.USD","LU1244550577.SGD","LU1979441026.SGD","LU0345770308.USD","LU0289961442.SGD","LU0345769128.USD","LU2023250504.SGD","LU0648001328.SGD","LLII","SG9999014559.SGD","BK4139","LU1201861249.SGD","LU0385154629.USD","LU2242646821.SGD","LU1670710588.SGD","LU1670710661.SGD","LU1043141123.HKD","AGNG","LU0353189680.USD","LU0965509101.SGD","ELIS","IE000MB6IJN5.SGD","LU2237443622.USD","FHLC","TMED","LU2129689605.HKD","LU1732799900.SGD","LU0237698245.USD","LU2265009873.SGD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU0787776722.HKD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664833759","title":"Australia's Monash IVF at over Four-Month High on Upbeat FY27 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2664833759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664833759?lang=en_us&edition=fundamental","pubTime":"2026-09-01 13:59","pubTimestamp":1788242381,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Monash IVF at over four-month high on upbeat FY27 outlook** Shares of Australia's Monash IVF GroupMVF.AXadvance as much as 12.3% to A$0.792, hitting their highest level since April 13** Stock extends gains after the fertility services provideroutlinesan upbeat FY27 outlook and declares a final dividend** Co says it expects FY27 performance to strengthen on market share gains, increased medical capacity and productivity initiatives** Adds, it plans to cut FY27 capital expenditure by about 50%** Co resumes dividends and declares a final dividend of 1.3 AU cents per share** Free cash flow improves to A$12.9 million from negative A$4.5 million a year earlier** YTD, stock up 4.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7113","BK7508","MVF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887889","title":"CSL's U.S. Agreements Remove Two Stock Overhangs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887889","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887889?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:22","pubTimestamp":1788229320,"startTime":"0","endTime":"0","summary":"0222 GMT - CSL's U.S. agreements on drug pricing and manufacturing expansion remove two overhangs on the stock, Morgans analyst Derek Jellinek says. He tells clients in a note that the Australia-based pharmaceutical company has reinforced its competitive position as a major U.S. manufacturer of plasma-derived therapies. Jellinek sees the key positive of CSL's Medicaid pricing agreement as the improved visibility on exposure to potential U.S. drug-pricing reform. As for its onshoring agreement, he reckons it gives greater certainty with regard to tariff exposure. Morgans has a last-published buy rating on the stock and a target price of 187.71 Australian dollars. Shares are up 0.9% at A$173.07.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","BK7067","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888926","title":"Racura Oncology Says First South Korean Site Activated for Phase 1 Drug Candidate Trial in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888926","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888926?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:24","pubTimestamp":1788222288,"startTime":"0","endTime":"0","summary":"Racura Oncology  said Ewha Womans University Seoul Hospital in South Korea was activated as the first site in the country added to the Cardioprotection and Anticancer Synergy phase one trial of its RC220 drug candidate in combination with doxorubicin in patients with advanced solid tumors, according to a Tuesday Australian bourse filing.The second and third South Korean sites, Severance Hospital and Samsung Medical Center, are set to be activated and opened for patient enrolment on Sept. 4 and Sept. 8, respectively. The final site, Asan Medical Center, has received all regulatory and governance approvals, with site activation awaiting execution of the study contract.Pre-screening of patients began at Ewha Womans University Seoul Hospital and Severance Hospital.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B66KJ199.SGD","LU2931357623.SGD","AEIS","LU1815336091.USD","LU0274383776.USD","BK7508","IE00B7SZL793.SGD","BK7067","LU2089985449.USD","IE00B19Z4B17.USD","LU0757428866.USD","BK4157","RAC.AU","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899648","title":"ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899648","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899648?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:12","pubTimestamp":1788221579,"startTime":"0","endTime":"0","summary":"Australian shares are poised to fall on Tuesday as oil prices surged more than 2.5% after renewed US-Iran military action heightened concerns over global supply disruptions and a prolonged conflict.Ov","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZYAU.AU","OZR.AU","CSL.AU","BK7104","IIGF.AU","QFN.AU","XAO.AU","IMLC.AU","XKO.AU","GIVE.AU","VAS.AU","QRE.AU","OZF.AU","XJO.AU","DACE.AU","STW.AU","VAP.AU","BEAR.AU","E200.AU","AUC.AU","IOZ.AU","BK7508","BK7501","BK7067","IISV.AU","BBOZ.AU","GEAR.AU","EIGA.AU","SLF.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886424","title":"CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886424","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886424?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:29","pubTimestamp":1788218965,"startTime":"0","endTime":"0","summary":"CSL  has entered agreements with the US Administration to lower medicine costs and expand its manufacturing footprint in the US, according to a Tuesday Australian bourse filing.The company will provide Medicaid access to its medicines at prices comparable to those in other developed countries and extend similar pricing to newly launched therapies for all US payers under an agreement with the US Department of Health and Human Services, per the filing.The company has also entered into an onshoring agreement with the US Department of Commerce for its planned $1.5 billion expansion in Kankakee, Illinois, aimed at increasing production of plasma-derived therapies, the filing said.The company said the agreements are not expected to materially affect fiscal 2027 financial results, while providing greater certainty over US drug pricing and potential Section 232 tariff exposure, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033885","title":"CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033885","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:28","pubTimestamp":1788215330,"startTime":"0","endTime":"0","summary":"CSL signs U.S. government agreements to lower drug prices for MedicaidCSL signed agreements with the US government to lower US drug prices, including Medicaid pricing comparable to other developed cou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbfGxJ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","BK7501","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0601},{"period":"6month","weight":0.0473},{"period":"1year","weight":0.1021},{"period":"ytd","weight":0.0446}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction